These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15392610)

  • 1. Qualitative differences among toxins and toxoids.
    BARR M; GLENNY AT
    J Hyg (Lond); 1949 Jun; 47(2):107-14. PubMed ID: 15392610
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of heat upon diphtheria toxoid-antitoxin floccules.
    BARR M
    Br J Exp Pathol; 1949 Feb; 30(1):61-72. PubMed ID: 18128096
    [No Abstract]   [Full Text] [Related]  

  • 3. The combination of antitoxin with toxin and toxoid.
    BARR M; GLENNY AT; STEVENS MF
    J Hyg (Lond); 1954 Sep; 52(3):379-96. PubMed ID: 13212041
    [No Abstract]   [Full Text] [Related]  

  • 4. Titration of diphtheria toxin, antitoxin and toxoid in tissue culture.
    ORMAY L; UJHELYI K
    Acta Microbiol Acad Sci Hung; 1961; 8():389-96. PubMed ID: 14482311
    [No Abstract]   [Full Text] [Related]  

  • 5. Serological studies of types A, B, and E botulinal toxins by passive hemagglutination and bentonite flocculation.
    Johnson HM; Brenner K; Angelotti R; Hall HE
    J Bacteriol; 1966 Mar; 91(3):967-74. PubMed ID: 5326104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of comparative experimental examinations of the therapeutic effect of antitoxin, formol toxoid and the combination of both on Cl. botulinum-(D)-toxin produced intoxication].
    KATIC RV
    Zentralbl Bakteriol Orig; 1956 Aug; 166(6):510-6. PubMed ID: 13361428
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on immunity to toxins of Clostridium botulinum. VI. Purification and detoxification of type D toxin and the immunological response to toxoid.
    CARDELLA MA; DUFF JT; WINGFIELD BH; GOTTFRIED C
    J Bacteriol; 1960 Mar; 79(3):372-8. PubMed ID: 13807649
    [No Abstract]   [Full Text] [Related]  

  • 8. A study of Clostridium botulinum toxoids. I. Type A Clostridium botulinum toxoid.
    VOROB'EV AA; VASIL'EV NN; PATRIKEYEV GT; ZYBIN VD; SHMELEV VM; KORNEV IS; ANAN'EVA EP
    Zh Mikrobiol Epidemiol Immunobiol; 1961; 32():1601-8. PubMed ID: 14040099
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of Clostridium botulinum toxoid. II. Type B toxoid.
    VOROB'EV AA; VASIL'EV NN; ENICHEV VM; PATRIKEYEV GT; SHEVELEV VM; ZYBIN VD; KORNEV IS; ANAN'EVA EP
    Zh Mikrobiol Epidemiol Immunobiol; 1961; 32():1851-6. PubMed ID: 14040098
    [No Abstract]   [Full Text] [Related]  

  • 10. THE PROTECTION OF RABBITS AGAINST INFECTION WITH STAPHYLOCOCCI BY IMMUNISATION WITH STAPHYLOCOAGULASE TOXIN OR TOXOID.
    HARRISON KJ
    J Pathol Bacteriol; 1964 Jan; 87():145-50. PubMed ID: 14106337
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on immunity to toxins of Clostridium botulinum. VIII. Immunological response of man to purified bivalent AB botulinum toxoid.
    FIOCK MA; DEVINE LF; GEARINGER NF; DUFF JT; WRIGHT GG; KADULL PJ
    J Immunol; 1962 Mar; 88():277-83. PubMed ID: 13893049
    [No Abstract]   [Full Text] [Related]  

  • 12. On the toxicity of the "toxoid" preparation responsible for the Kyoto catastrophe in 1948.
    KUROKAWA M; MURATA R
    Jpn J Med Sci Biol; 1961 Dec; 14():249-56. PubMed ID: 14460782
    [No Abstract]   [Full Text] [Related]  

  • 13. Laboratory evaluation of a trivalent toxoid for botulism.
    APPLETON GS; WHITE PG
    Am J Vet Res; 1959 Jan; 20():170-2. PubMed ID: 13793982
    [No Abstract]   [Full Text] [Related]  

  • 14. Experimental study of the immunogenic properties of combined anaerobic toxoids. II. Study of the immunological efficacy of sextuple toxoid on remote reimmunization.
    VYGODCHIKOV GV; VOROB'EV AA; SALTYKOV RA; LARINA IA; SHEVELEV VM
    Zh Mikrobiol Epidemiol Immunobiol; 1961; 32():1267-71. PubMed ID: 14040128
    [No Abstract]   [Full Text] [Related]  

  • 15. The preparation and properties of staphylocoagulase toxoid.
    HARRISON KJ
    J Pathol Bacteriol; 1963 Apr; 85():341-8. PubMed ID: 13952994
    [No Abstract]   [Full Text] [Related]  

  • 16. TOXOID FORMATION OF PNEUMOLYSIN AND STREPTOLYSIN O BY GLUCURONAMIDE.
    OGASAWARA K; KATO N; TAKAGI M
    Nagoya J Med Sci; 1965 Jul; 27():209-17. PubMed ID: 14338194
    [No Abstract]   [Full Text] [Related]  

  • 17. USE OF STAPHYLOCOCCUS TOXOID AND AUTOGENOUS VACCINE IN THE TREATMENT OF BOILS.
    PAULSON G; BUFFALOE WJ; OSTERHOUT S
    N C Med J; 1963 Sep; 24():385-6. PubMed ID: 14045666
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of the products of protein splitting in the culture medium on toxin formation. II. Antigen and immunogenic properties of diphtheria toxins (toxoids) obtained on the medium, digested by 2 enzymes, during culture of the Weisensee strain].
    PAVLOV PV; LEONOVA AG
    Zh Mikrobiol Epidemiol Immunobiol; 1961 Jan; 32():95-9. PubMed ID: 13733593
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of a purified cholera toxoid. II. Preparation of a stable, antigenic toxoid by reaction of purified toxin with glutaraldehyde.
    Rappaport RS; Bonde G; McCann T; Rubin BA; Tint H
    Infect Immun; 1974 Feb; 9(2):304-17. PubMed ID: 4205946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on cholera toxin and antitoxin.
    Ungar J; Stanić M; Chariatte N; Varallyay SJ
    J Gen Microbiol; 1970 Nov; 64(1):1-10. PubMed ID: 5516606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.